<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200123046230N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-02-22</date_registration>
      <primary_sponsor>Faculty of Dentistry, Islamic Azad University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the Effect of Low-level Laser Therapy on the Neurosensory Disturbances Following Inferior Alveolar Nerve Lateralization Surgery: A Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Effect of Low-level Laser Therapy on the Neurosensory Disturbances Following Inferior Alveolar Nerve Lateralization Surgery: A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45621</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple individual randomization is performed with the coin toss for each participant and receives one side based on the laser coin toss, Blinding description: After obtaining consent from patients, randomly assigned to the case group (low power laser) and control group (no laser irradiation) for each patient The device is switched off and the patient assumes that both sides are laser treated
The researcher is also unaware of the laser being irradiated and the laser treatment process is performed by the technician.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Inferior alveolar nerve neurosensory disturbance.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Surgery will be performed by one of the experienced professors with the same standard protocol and materials. After surgery, the intervention group was treated with laser therapy with a 0.3 watt diode laser and 6 joule power (InGaAlP; wavelength 660nm; Thor DD2 Control Unit, Thor, London, UK) for 8 sessions at 72 intervals. It will be placed in the oral alveolar nerve pathway orally for 20 seconds per square centimeter per session. Intervention 2: Control group: Surgery will be performed by one of the experienced professors with the same standard protocol and materials. After surgery, the control group is exposed to placebo laser irradiation with a 0.3 watt laser diode and 6 joules of power (InGaAlP; wavelength 660nm; Thor DD2 Control Unit, Thor, London, UK ) In 8 sessions at 72 hours intervals for 20 seconds per square centimeter, the inferior alveolar nerve pathway will be inhaled orally but the device will be switched off and the laser will not be illuminated.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Arash Azaripour Esfahani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 112 , Hodhod building 1 , North Navab Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1319813719</zip>
        <telephone>+98 21 6638 4856</telephone>
        <email>arashazaripour@gmail.com</email>
        <affiliation>Faculty of Dentistry, Islamic Azad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arash azaripour Esfahani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 112 , Hodhod Building 1 , North Navab Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1319813719</zip>
        <telephone>+98 21 6638 4856</telephone>
        <email>arashazaripour@gmail.com</email>
        <affiliation>Faculty of Dentistry, Islamic Azad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients Applicant for Dental Implant Therapy on Both Posterior Mandible with Insufficient Bone Height who candidates for inferior alveolar nerve lateralization surgery</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of facial fractures
History of long term headache
Psychological disorders
Neurologic disorders
Diabetes
History of taking anti epileptic drugs
Clear nerve damage during surgery
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G50.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other disorders of trigeminal nerve</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Surgery will be performed by one of the experienced professors with the same standard protocol and materials. After surgery, the intervention group was treated with laser therapy with a 0.3 watt diode laser and 6 joule power (InGaAlP; wavelength 660nm; Thor DD2 Control Unit, Thor, London, UK) for 8 sessions at 72 intervals. It will be placed in the oral alveolar nerve pathway orally for 20 seconds per square centimeter per session.</i_keyword>
      <i_keyword>Control group: Surgery will be performed by one of the experienced professors with the same standard protocol and materials. After surgery, the control group is exposed to placebo laser irradiation with a 0.3 watt laser diode and 6 joules of power (InGaAlP; wavelength 660nm; Thor DD2 Control Unit, Thor, London, UK ) In 8 sessions at 72 hours intervals for 20 seconds per square centimeter, the inferior alveolar nerve pathway will be inhaled orally but the device will be switched off and the laser will not be illuminated</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sensory function of the inferior alveolar nerve. Timepoint: Before surgery and 1, 3 and 6 months after surgery. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Faculty of Dentistry, Islamic Azad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-27</approval_date>
        <contact_name>Ethics committee of Tehran Azad University of Medical Sciences - Faculty of Dentistry</contact_name>
        <contact_address>No. 112 , Hodhod 1 building , North navab highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
